|
|
Volumn 9, Issue 9, 2000, Pages 933-934
|
|
Biological sex analysis in clinical research
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALOSETRON;
ASTEMIZOLE;
CISAPRIDE;
GREPAFLOXACIN;
ION CHANNEL;
MIBEFRADIL;
SEX HORMONE;
TERFENADINE;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
CLINICAL RESEARCH;
COMPUTER PROGRAM;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
EDITORIAL;
FEMALE;
HEART ARRHYTHMIA;
HORMONE ACTION;
HUMAN;
INFORMATION PROCESSING;
IRRITABLE COLON;
MALE;
NATIONAL HEALTH SERVICE;
NONHUMAN;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
SEX DIFFERENCE;
SEXUALITY;
SIDE EFFECT;
STATISTICAL ANALYSIS;
CLINICAL TRIALS;
DATA INTERPRETATION, STATISTICAL;
DISEASE MODELS, ANIMAL;
DRUG EVALUATION;
FEMALE;
GUIDELINES;
HUMANS;
MALE;
NATIONAL INSTITUTES OF HEALTH (U.S.);
RESEARCH DESIGN;
RESEARCH SUPPORT;
SEX CHARACTERISTICS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
WOMEN'S HEALTH;
|
|
EID: 0033636133
PISSN: 15246094
EISSN: None
Source Type: Journal
DOI: 10.1089/15246090050199919 Document Type: Editorial |
|
Times cited : (5)
|
|
References (13)
|
